At New York Oncology Hematology, our providers are experts in treating patients diagnosed with a gynecologic malignancy using sophisticated surgical techniques and technologies, leading-edge radiation technologies and the latest in chemotherapy treatments and targeted therapies.
Gynecologic cancer refers to a group of cancers that begin in a woman's reproductive organs.
Ovarian epithelial cancer begins in the tissue that covers the ovaries, which are the reproductive glands that produce eggs (ova).
Cervical cancer is a type of gynecologic cancer that begins developing in a woman's cervix, which is the lower, narrow part of the uterus.
Endometrial cancer or uterine cancer is a gynecologic cancer that forms in the tissue lining the uterus (the small, hollow, pear-shaped organ in a woman’s pelvis in which a fetus develops).
Each of these cancers is unique with different causes, risk factors, and treatment options.
Therefore, understanding more about women's cancers, their risk factors, and their symptoms can lower your chance of developing an advanced stage gynecologic cancer.
At New York Oncology Hematology, our gynecological oncologists and surgeons focus on diagnosing, treating, and managing cancers affecting female reproductive organs, including the cervix, fallopian tubes, uterus, ovaries, vagina and vulva.
Some of our pre-cancerous diagnostic and treatments, such as colposcopies, LEEP, conizations, and biopsies, can be performed in the office.
Genetic research plays an increasingly important role in the diagnosis and treatment of cancer. To help patients and their families understand and evaluate their risk for certain diseases, New York Oncology Hematology offers a comprehensive hereditary risk assessment program.
Our dedicated team of medical oncologists and radiation oncologists, including gynecologic cancer specialists, use the latest cancer treatment technologies to create a unique treatment plan for each patient.
©2024 New York Oncology Hematology. All rights reserved.